Efficacy of Methylsulfonylmethane Supplementation on Osteoarthritis of The Knee: A Randomized Controlled Study
Primary Purpose
Knee Osteoarthritis
Status
Completed
Phase
Not Applicable
Locations
Study Type
Interventional
Intervention
Methylsulfonylmethane (MSM)
Sponsored by
About this trial
This is an interventional trial for Knee Osteoarthritis
Eligibility Criteria
Inclusion Criteria:
- symptomatic knee OA for at least 6 months according to the clinical criteria of the American College of Rheumatology (ACR)
- radiographic confirmed knee OA according to the Kellgren & Lawrence scale
Exclusion Criteria:
- acute septic arthritis
- inflammatory arthritis
- any other type of arthritis
- history of knee buckling or recent knee injury
- lack of physical or mental bility to perform or comply with the treatment procedure
- diabetes mellitus
- fibromyalgia or other chronic pain syndromes
- concurrent anti-coagulant/anti-platelet drugs
- arthroscopy or intra-articular injections in the previous 3 months
Sites / Locations
Arms of the Study
Arm 1
Arm Type
Experimental
Arm Label
Purified MSM
Arm Description
Outcomes
Primary Outcome Measures
WOMAC questionnaire
Secondary Outcome Measures
Full Information
NCT ID
NCT01188213
First Posted
August 21, 2010
Last Updated
August 24, 2010
Sponsor
Assaf-Harofeh Medical Center
1. Study Identification
Unique Protocol Identification Number
NCT01188213
Brief Title
Efficacy of Methylsulfonylmethane Supplementation on Osteoarthritis of The Knee: A Randomized Controlled Study
Study Type
Interventional
2. Study Status
Record Verification Date
May 2005
Overall Recruitment Status
Completed
Study Start Date
undefined (undefined)
Primary Completion Date
undefined (undefined)
Study Completion Date
undefined (undefined)
3. Sponsor/Collaborators
Name of the Sponsor
Assaf-Harofeh Medical Center
4. Oversight
Data Monitoring Committee
No
5. Study Description
Brief Summary
The aim of this study was to determine the efficacy of methylsulfonylmethane (MSM) in treating patients with knee OA.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Knee Osteoarthritis
7. Study Design
Study Phase
Not Applicable
8. Arms, Groups, and Interventions
Arm Title
Purified MSM
Arm Type
Experimental
Intervention Type
Dietary Supplement
Intervention Name(s)
Methylsulfonylmethane (MSM)
Primary Outcome Measure Information:
Title
WOMAC questionnaire
10. Eligibility
Sex
All
Minimum Age & Unit of Time
40 Years
Maximum Age & Unit of Time
70 Years
Eligibility Criteria
Inclusion Criteria:
symptomatic knee OA for at least 6 months according to the clinical criteria of the American College of Rheumatology (ACR)
radiographic confirmed knee OA according to the Kellgren & Lawrence scale
Exclusion Criteria:
acute septic arthritis
inflammatory arthritis
any other type of arthritis
history of knee buckling or recent knee injury
lack of physical or mental bility to perform or comply with the treatment procedure
diabetes mellitus
fibromyalgia or other chronic pain syndromes
concurrent anti-coagulant/anti-platelet drugs
arthroscopy or intra-articular injections in the previous 3 months
12. IPD Sharing Statement
Citations:
PubMed Identifier
21708034
Citation
Debbi EM, Agar G, Fichman G, Ziv YB, Kardosh R, Halperin N, Elbaz A, Beer Y, Debi R. Efficacy of methylsulfonylmethane supplementation on osteoarthritis of the knee: a randomized controlled study. BMC Complement Altern Med. 2011 Jun 27;11:50. doi: 10.1186/1472-6882-11-50.
Results Reference
derived
Learn more about this trial
Efficacy of Methylsulfonylmethane Supplementation on Osteoarthritis of The Knee: A Randomized Controlled Study
We'll reach out to this number within 24 hrs